2m 2m 2m 2m 2m 2m 2m
POLYPID (PYPD)
NASDAQ
$4.76-$0.12 (-2.36%)
Price as of Jun 03, 2026 5:05 PM EDT- $87.3MMarket Cap
- 54.85%1-Year Change
- BiotechnologyIndustry
POLYPID (PYPD)
$4.76-$0.12 (-2.36%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 2.0M +109.21% | 945,000 -20.99% | 1.2M N/A | N/A N/A | |
Research and Development Expense | -23.8M +4.37% | -22.8M +41.26% | -16.1M -42.31% | -28.0M -8.39% | |
Depreciation and Amortization Expense | 1.5M -10.11% | 1.6M -10.98% | 1.8M +5.87% | 1.7M +53.94% | |
Total Operating Expenses | 7.2M +68.10% | 4.3M -22.63% | 5.5M -31.05% | 8.0M -16.64% | |
Operating Profit | -33.0M +17.62% | -28.0M +22.57% | -22.9M -41.20% | -38.9M -9.87% | |
Interest Income | 517,000 +16.97% | 442,000 -19.34% | 548,000 +105.24% | 267,000 -42.95% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 517,000 +16.97% | 442,000 -19.34% | 548,000 +105.24% | 267,000 -42.95% | |
Total Nonoperating Income and Expense | -685,000 -27.97% | -951,000 +2.37% | -929,000 +72.04% | -540,000 -199.26% | |
Income before Taxes | -34.2M +17.89% | -29.0M +21.79% | -23.8M -39.65% | -39.4M -8.62% | |
Income Taxes | 5,000 -88.10% | 42,000 -39.13% | 69,000 -46.51% | 129,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -34.2M +17.73% | -29.0M +21.61% | -23.9M -39.67% | -39.6M -7.15% | |
Net Income from Continuing Operations Applicable to Common | -34.2M +17.89% | -29.0M +21.79% | -23.8M -39.84% | -39.6M -7.15% | |
Basic EPS and Net Income | 2.09 -57.43% | 4.91 -71.10% | 16.99 +732.84% | 2.04 -10.53% | |
Diluted EPS and Net Income | 2.09 -57.43% | 4.91 -71.00% | 16.93 +729.90% | 2.04 -10.53% | |
Basic Weighted Average Shares | 16.4M +176.55% | 5.9M +321.04% | 1.4M -92.77% | 19.4M +3.77% | |
Diluted Weighted Average Shares | 16.4M +176.55% | 5.9M +316.02% | 1.4M -92.68% | 19.4M +3.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.4M -59.07% | 15.6M +194.61% | 5.3M -37.92% | 8.6M -12.90% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.4M -59.07% | 15.6M +194.61% | 5.3M -37.92% | 8.6M -12.90% | |
Total Current Assets | 15.2M -8.12% | 16.6M +173.17% | 6.1M -57.26% | 14.2M -59.23% | |
Accumulated Depreciation | 10.9M +15.48% | 9.4M +20.80% | 7.8M +30.49% | 6.0M +40.46% | |
Property and Plant and Equipment and Net | 5.1M -16.15% | 6.1M -20.29% | 7.6M -17.58% | 9.2M +5.55% | |
Total Long-Term Assets | 7.1M -18.12% | 8.6M +9,839.08% | 87,000 -12.12% | 99,000 -85.07% | |
Total Assets | 22.3M -11.55% | 25.2M +64.06% | 15.4M -40.81% | 26.0M -41.29% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 988,000 -85.44% | 6.8M +69.55% | 4.0M -0.52% | 4.0M N/A | |
Total Current Liabilities | 7.7M -38.97% | 12.7M +74.05% | 7.3M -14.81% | 8.6M +5.91% | |
Total Long-Term Debt | 7.9M +1,151.26% | 634,000 -90.06% | 6.4M -15.78% | 7.6M N/A | |
Total Long-Term Liabilities | 3.6M -25.95% | 4.9M -52.32% | 10.2M +173.64% | 3.7M +74,320.00% | |
Total Liabilities | 8.4M -39.92% | 14.0M +71.41% | 8.1M -16.28% | 9.7M +20.43% | |
Retained Earnings | -301.5M +12.78% | -267.3M +12.18% | -238.3M +11.13% | -214.4M +22.62% | |
Total Stockholders Equity | 11.0M +42.80% | 7.7M +466.60% | -2.1M -135.96% | 5.8M -83.79% | |
Total Shares Outstanding | 18.2M +78.63% | 10.2M +516.30% | 1.7M -91.67% | 19.9M +5.84% | |
Cash Flow | |||||
Cash from Operating Activities | -27.9M +26.94% | -22.0M +27.43% | -17.2M -49.77% | -34.3M +5.96% | |
Capital Expenditures | 210,000 +176.32% | 76,000 -61.22% | 196,000 -88.91% | 1.8M -33.40% | |
Cash from Investing Activities | -6.7M +1,931.52% | -330,000 -108.68% | 3.8M -77.05% | 16.6M -55.08% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 25.4M -21.74% | 32.4M +224.94% | 10.0M -39.27% | 16.4M +1,488.78% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -143.79% +0.56% | -142.99% +23.86% | -115.45% +2.45% | -112.69% +58.82% | |
Return on Equity | -366.29% -64.74% | -1,038.73% -18.76% | -1,278.60% +575.37% | -189.32% +141.61% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.97 +50.55% | 1.31 +56.95% | 0.83 -49.82% | 1.66 -61.50% | |
Cash Ratio | 0.83 -32.93% | 1.23 +69.26% | 0.73 -27.12% | 1.00 -17.76% | |
Debt-to-Equity Ratio | 0.81 -15.82% | 0.97 +119.50% | -4.95 -348.94% | 1.99 N/A | |
Debt-to-Assets Ratio | 0.40 +35.88% | 0.29 -56.43% | 0.68 +51.23% | 0.45 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow